We describe the multiplex immunostaining method, involving the use of a cocktail of four antibodies, which is effective for the diagnosis of non-small cell lung cancer. In our examination, the staining showed 97% sensitivity and 100% specificity for the diagnosis of adenocarcinoma, and 100% sensitivity and specificity for the diagnosis of squamous cell carcinoma.